Showing results (291-300 of 385) with videos related to

Sort By:
Pageof 39
The Journal of Clinical Endocrinology and Metabolism|March 7, 2013
Randomized clinical trial of vitamin D3 doses on prostatic vitamin D metabolite levels and ki67 labeling in prostate cancer patientsDennis Wagner, Dominique Trudel, Theodorus Van der Kwast, et al.
Oncotarget|October 4, 2014
Integrated analysis of epigenomic and genomic changes by DNA methylation dependent mechanisms provides potential novel biomarkers for prostate cancerNicole M A White-Al Habeeb, Linh T Ho, Ekaterina Olkhov-Mitsel, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|December 23, 2021
The association of statin subgroups with lower urinary tract symptoms following a prostate biopsyHanan Goldberg, Faizan K Mohsin, Thenappan Chandrasekar, et al.
BJU International|February 1, 2011
Long-term follow-up of T1 high-grade bladder cancer after intravesical bacille Calmette-Guérin treatmentDavid M Kakiashvili, Bas W G van Rhijn, Greg Trottier, et al.
Prostate Cancer and Prostatic Diseases|July 10, 2020
The deleterious association between proton pump inhibitors and prostate cancer-specific mortality - a population-based cohort studyHanan Goldberg, Faizan K Mohsin, Refik Saskin, et al.
The Journal of Urology|January 25, 2003
Soy consumption and phytoestrogens: effect on serum prostate specific antigen when blood lipids and oxidized low-density lipoprotein are reduced in hyperlipidemic menDavid J A Jenkins, Cyril W C Kendall, Mario A D'Costa, et al.
The Journal of Urology|June 5, 2020
Does the Visibility of Grade Group 1 Prostate Cancer on Baseline Multiparametric Magnetic Resonance Imaging Impact Clinical Outcomes?Dominik Deniffel, Emmanuel Salinas, Marc Ientilucci, et al.
European Urology|July 19, 2018
Active Surveillance Magnetic Resonance Imaging Study (ASIST): Results of a Randomized Multicenter Prospective TrialLaurence Klotz, Andrew Loblaw, Linda Sugar, et al.
The Oncologist|March 30, 2023
Niraparib with Abiraterone Acetate and Prednisone for Metastatic Castration-Resistant Prostate Cancer: Phase II QUEST Study ResultsKim N Chi, Neil Fleshner, Vincenzo Emanuele Chiuri, et al.
Plos One|December 1, 2021
Genomic characterization of non-schistosomiasis-related squamous cell carcinoma of the urinary bladder: A retrospective exploratory studyEsmail M Al-Ezzi, Zachary W Veitch, Samer H Salah, et al.
Pageof 39